142 related articles for article (PubMed ID: 24399307)
1. Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin.
Fujisawa T; Takeda J; Aoki K; Ishikawa T
Ann Hematol; 2014 Sep; 93(9):1621-3. PubMed ID: 24399307
[No Abstract] [Full Text] [Related]
2. Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.
Mandelli F; Latagliata R; Avvisati G; Fazi P; Rodeghiero F; Leoni F; Gobbi M; Nobile F; Gallo E; Fanin R; Amadori S; Vignetti M; Fioritoni G; Ferrara F; Peta A; Giustolisi R; Broccia G; Petti MC; Lo-Coco F;
Leukemia; 2003 Jun; 17(6):1085-90. PubMed ID: 12764372
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
Breccia M; Latagliata R; Carmosino I; Cannella L; Diverio D; Guarini A; De Propris MS; Petti MC; Avvisati G; Cimino G; Mandelli F; Lo-Coco F
Haematologica; 2008 Dec; 93(12):1918-20. PubMed ID: 18945746
[No Abstract] [Full Text] [Related]
4. Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
Lou Y; Qian W; Meng H; Mai W; Tong H; Tong Y; Huang J; Jin J
Hematol Oncol; 2014 Mar; 32(1):40-6. PubMed ID: 23963734
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
Esteve J; Escoda L; Martín G; Rubio V; Díaz-Mediavilla J; González M; Rivas C; Alvarez C; González San Miguel JD; Brunet S; Tomás JF; Tormo M; Sayas MJ; Sánchez Godoy P; Colomer D; Bolufer P; Sanz MA;
Leukemia; 2007 Mar; 21(3):446-52. PubMed ID: 17205057
[TBL] [Abstract][Full Text] [Related]
6. Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report.
Ciccone M; Rigolin GM; Viglione GM; Borrelli M; Serino ML; Cuneo A
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):721-3. PubMed ID: 18832917
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
Eardley AM; Heller G; Warrell RP
Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987
[TBL] [Abstract][Full Text] [Related]
8. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?
Mallo M; Salido M; Espinet B; Cervera J; Canellas A; Pajuelo JC; Pedro C; Florensa L; Sanz MA; Solé F
Leuk Res; 2007 Sep; 31(9):1315-7. PubMed ID: 17092559
[No Abstract] [Full Text] [Related]
9. Massive postpartum hemorrhage after chemotherapy in a patient with acute promyelocytic leukemia.
Aoki A; Yoneda N; Yoneda S; Miyazono T; Sugiyama T; Saito S
J Obstet Gynaecol Res; 2011 Nov; 37(11):1759-63. PubMed ID: 21790892
[TBL] [Abstract][Full Text] [Related]
10. Time to abandon traditional chemotherapy for acute promyelocytic leukaemia?
Ravandi F; Kantarjian H
Lancet Oncol; 2015 Oct; 16(13):1274-5. PubMed ID: 26384240
[No Abstract] [Full Text] [Related]
11. Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases.
Ferrara F; Selleri C; Mele G; Serio B; Palmieri S; Pocali B; Pane F; Rotoli B
Ann Hematol; 2004 Jul; 83(7):484-6. PubMed ID: 14730393
[TBL] [Abstract][Full Text] [Related]
12. Acute pancreatitis during all-trans-retinoic acid treatment for acute promyelocytic leukemia in a patient without overt hypertriglyceridemia.
Teng HW; Bai LY; Chao TC; Wang WS; Chen PM
Jpn J Clin Oncol; 2005 Feb; 35(2):94-6. PubMed ID: 15709095
[TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid in acute promyelocytic leukemia.
Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
[TBL] [Abstract][Full Text] [Related]
14. Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA).
Klein SK; Biemond BJ; van Oers MH
Ann Hematol; 2007 Dec; 86(12):917-8. PubMed ID: 17619879
[No Abstract] [Full Text] [Related]
15. Central nervous system relapse in acute promyelocytic leukemia.
Colovic N; Bogdanovic A; Miljic P; Jankovic G; Colovic M
Am J Hematol; 2002 Sep; 71(1):60-1. PubMed ID: 12221680
[No Abstract] [Full Text] [Related]
16. New strategies for the treatment of acute promyelocytic leukaemia.
Mandelli F
J Intern Med Suppl; 1997; 740():23-7. PubMed ID: 9350178
[TBL] [Abstract][Full Text] [Related]
17. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
[TBL] [Abstract][Full Text] [Related]
18. Updates on the treatment of acute promyelocytic leukemia.
Tallman MS
Clin Adv Hematol Oncol; 2010 Feb; 8(2):89-90. PubMed ID: 20386527
[No Abstract] [Full Text] [Related]
19. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
Breccia M; Cimino G; Alimena G; De Carolis S; Lo Coco F; Mandelli F
Haematologica; 2002 Feb; 87(2):ELT12. PubMed ID: 11836189
[No Abstract] [Full Text] [Related]
20. Occurrence of myelodysplasia/acute myeloid leukemia 'on therapy' in two patients with acute promyelocytic leukemia.
Chelghoum Y; Plesa A; Ducastelle S; Elhamri M; Thomas X
Indian J Cancer; 2016; 53(1):59-60. PubMed ID: 27146742
[No Abstract] [Full Text] [Related]
[Next] [New Search]
